Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Blood-borne specialty page provides blood-borne-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

BLOOD-BORNE DISEASES NEWS - Page 2

Rapid Tests Aren't Always Accurate in Testing for HIV, HCV and HBV
Blood sample testing in African countries using rapid tests is a mixed message. Accuracy in HIV improved, but accuracy in hepatitis B and C testing did not.
Intrauterine Drug Exposure Linked With Increased Risk for Pediatric HCV
Results from a study at a Cincinnati hospital point to the importance of testing at-risk infants for HCV as the opioid crisis impacts prevalence of the infection.
DRC Ebola Outbreak Remains Public Health Emergency of International Concern
Leaders from the WHO and various impacted countries met to assess the risks of the Ebola outbreak in the Democratic Republic of the Congo and the future of the outbreak response.  
 
Diluted Ebola Vaccine Effective in Animal Model Study
Scientists from the National Institutes of Health are hopeful that diluting a dose of the VSV vaccine could be efficacious and stretch vaccine supplies even further.
HCV-Associated Mortality Continues Decline in US, but Gaps Remain
Although the overall mortality rate for HCV has declined, clinicians will have to focus on individuated factors to address lingering barriers.
Ebola Lessons from Sweden: Health Care Preparedness is Vital
A patient was evaluated for Ebola in a Swedish hospital. Here's what we should take away from it.
Where to Treat Uncomplicated HCV? Assessing the Impact of Shifting Care From Specialists to PCPs
One promising proposal to greatly increase access to DAA HCV therapy is to keep this treatment with appropriately trained PCPs, in contrast with referring patients to infectious disease, gastroenterology, or hepatology subspecialists.
Vaccine Candidate Elicits Immune Responses, But Does Not Protect Against Chronic HCV
The phase 1/2 trial of a prime-boost vaccine to prevent chronic HCV infection was completed in an at-risk population of in people who inject drugs.
 
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?